Cardiosense is a digital health company that combines wearable technology and artificial intelligence to enhance patient health outcomes. The mission focuses on leveraging physiological waveform data to predict cardiac illnesses, enabling timely interventions that promote longer, healthier lives. To realize this mission, Cardiosense develops a physiological waveform AI platform that produces predictive biomarkers for cardiac disease detection and management. The company has created a variety of innovative digital tools, multi-sensor devices, and analytical algorithms designed to help healthcare providers identify clinical deterioration early, tailor personalized treatments, and improve patient care. With a team of experts in data science, healthcare, and electronics, Cardiosense partners with leading medical and academic institutions to pioneer advanced solutions in patient waveform monitoring and analytics, ultimately transforming the management of cardiac health.